SP,RP - NYM
Carrasco returned strong from his battle with leukemia in 2019 to post a 2.91 ERA and 1.21 WHIP in 2020. Pretty much everything was back to normal with Carrasco's production other than his walk rate, where he went from several years under 6% to a 9.6% mark in 2020. That's likely just the oddities of a shortened season, however, and now that Carrasco is with the Mets, his stock should only go up. Not only should the Mets provide him with a better chance at wins, but their infield defense should be above average and Carrasco will play in a more favorable park. In other words, it's all gravy for Carrasco, and he can be drafted as an SP2.
We can completely write off Carrasco's 2019 season as the right-hander was going through a battle with leukemia. The 33-year-old heroically bounced back last summer, posting a 2.91 ERA to go along with a 1.21 WHIP and 82 strikeouts in 64 innings. A 9.6% walk rate is mildly concerning, but Carrasco misses enough bats that he should still be viewed as a reliable SP2/3. The perception around him seems to be that he isn't durable, but Carrasco started 30 games three times from 2015-18.